Orthotopic Heart Transplantation and Mechanical Circulatory Support in Cancer Survivors: Challenges and Outcomes

Table 1

Factors that may influence outcome after advanced heart failure therapies in adult patients with anthracycline-induced cardiomyopathy [1].

Patient characteristics that may favor advanced heart failure therapies in anthracycline-induced end-stage heart failure	Patient characteristics that may oppose advanced heart failure therapies in anthracycline-induced end-stage heart failure
Lower body surface area	Higher rates of malignancy^*
Lower likelihood of diabetes	Higher rates of infection
Lower likelihood of hypertension	Impact of prior thoracic radiation therapy on sternotomy complications
Lower likelihood of smoking	Greater need for right ventricular assist device
	Higher rates of perioperative bleeding
Younger age	Higher rates of destination-therapy (as opposed to bridge to transplantation)^#

 ^*Applies to orthotopic heart transplantation but not left ventricular assist device.
^#Applies to left ventricular assist device but not to orthotopic heart transplantation.